Seth E. Cockrum
The Third Time is the Charm for Sanofi in its IPR Challenge of Immunex’s ʼ487 Patent
Biosimilars Law Bulletin ·
Sandoz Files Declaratory Judgment of Non-Infringement For Filgrastim-Related Patent
Biosimilars Law Bulletin ·
The PTAB Denies Institution of Two IPRs Involving a Patent Directed to the Treatment of Hemophilia B
Biosimilars Law Bulletin ·
FDA Issues Guidance Documents on the “Deemed to be a License” Transition Provision of the BPCIA
Biosimilars Law Bulletin ·
FDA Proposes Amendment to the Definition of “Biological Product”
Biosimilars Law Bulletin ·